Funding for this research was provided by:
Received: 24 October 2020
Accepted: 12 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: the study was approved by the Internal Review Board of the University of L’Aquila (Italy) and patients gave written informed consent according to the Declaration of Helsinki.
: not applicable.
: RO declares financial and non-financial relationships with Eli Lilly and Novartis, non-financial relationships with Allergan, and Teva; SS had a financial relationship (lecturer or member of advisory board) with Abbott, Allergan, Novartis, Teva, and Eli Lilly; GA has received funds for congress participation from Innovet Italia Srl, Epitech Group and Lusofarmaco; MAG received funds for congress participation from IBSA; AC, IF, AG, MA, MM, FM, SV, DC, CM, and FP declare no competing interests.